Опубликовать статью

Информационное партнерство

Инфоресурсы

Контакты

«

Vol. 19, Art. 20 (pp. 269-280)    |    2018       

»

Early features of malignancy in patients with pheochromocytoma by gas chromatography mass spectrometry

Ivanushko M.A., Velikanova L.I., Vorokhobina N.V., Shafigullina Z.R.

Federal Budget Institution of Higher Education ?North-Western State Medical University named after I.I. Mechnikov? under the Ministry of Public Health of the Russian Federation, Saint-Petersburg, Russian Federation

Brief summary

The article presents an analysis of urinary steroid profiling getting by gas chromatography-mass-spectrometry (GC-MS) of 52 patients with pheochromocytoma, 12 patients had pheochromocytoma (PCC) with aggressive course of the tumor based on PASS score greater than 4 (PCC + MP). The control group consisted from 28 patients with adrenocortical adenoma (ACA) without malignant potential (MP). Urinary excretion (UE) of androgens (etiocholanolone, dehydroepiandrosterone and its metabolites), progestin metabolites [pregnanediol (P2), pregnanetriol (P3), pregentriol (dP3), 16-OH-pregnenodiol (16dP2) tetrahydro-11-deoxycortisol (TNS) was increased in patients with PCC and aggressive course of the tumor in comparison with patients with ACA without MP. Non-classical 5-еne-pregnenes: 16-hydroxypregnenolone (16dP), 21dP, dP3-3β, 16dP2-3β, were detected in patients with PCC+MP. Increased urinary excretion of androgens and THS in combination with the elevation of P2, P3 and the presence of non-classical 5-ene-pregnens detected by GC-MS analyses had high sensitivity and specificity in diagnostic of malignancy PCC and may be it?s early features.


Key words

pheochromocytoma, adrenal gland tumor, malignant potential, gaschromatography-mass-spectrometry, urinary steroid profiling

Reference list

1. Volkova, N.I. Osobennosti kliniki i diagnostiki feohromocitomi na sovremennom etape / N.I. Volkova, O.I. Kit, M.I. Porksheyan, S.N.?Dimitriadi // Endokrinnaya hiryrgiya. - 2015. - T. 9, N 2. - C. 24-30.


2. Zelinka, T. Pheochromocytoma-why is its early diagnosis so important for patient? / T. Zelinka, J. Widimský // Vnitr Lek. -2015. -Vol. 61. - P. 487-491.


3. Zuber, S.M. Hypertension in pheochromocytoma: Characteristics and treatment / S.M. Zuber, V. Kantorovich, K. Pacak // Endocrinology Metabolism Clinics of North America. - 2011. - Vol. 40, N 2. - P. 295-311.


4. Melnichenko, G.A. Klinicheskie rekomendacii Rossiĭskoĭ associacii endokrinologov po diagnostike i lecheniu feohromocitomi/paragangliomi / G.A. Melnichenko [i dr.] // Endokrinnaya hiryrgiya. - 2015. - T. 9, N 3. - S.?15-33.


5. de Wailly, P. Malignant pheochromocytoma: New malignancy criteria / P. de Wailly [et al.] // Langenbecks Arch Surg. - 2012. - Vol. 397. - P. 239-246.


6. Lam, A.K. Update on adrenal tumours in 2017 world health organization (WHO) of endocrine tumours / A.K. Lam // Endocr. Pathol. - 2017. - Vol. 28. - P.?213-227.


7. Kloeppel, G. Pathology and genetics of endocrine organs / G. Kloeppel, R. Lloyd, R Osamura, J. Roasi. -4thed. -Lyon: IARC Press, 2017. - P. 179-195.


8. Lloyd, R.V. WHO Classification of Tumours of Endocrine Organs / R.V. Lloyd, R.Y. Osamura, G. Klöppel, J. Rosai. - 4th ed. - IACR, Lyon, 2017. - 355 p.


9. Turchini, J. Pathology and genetics of phaeochromocytoma and paraganglioma/ J.?Turchini [et al.] // Histopathology. - 2018. - Vol. 72. - P. 97-105.


10. Mlika, M. Prognostic value of Pheochromocytoma of the adrenal gland scaled score (Pass score) tests to separate benign from malignant neoplasms / M. Mlika [et al.] // Tunis Med. -2013. - Vol. 91. - P. 209-215.


11. Carlsen, E. Pheochromocytama, PASS and Immunohistochemistry / E. Carlsen [et?al.] // Horm Metab Res. - 2009. - Vol. 41. - P. 715-719.


12. Plouin, P.F. European Society of Endocrinology Clinical Practice Guideline for longterm follow-up of patients operated on for a phaeochromocytoma or a paraganglioma / P.F. Plouin [et al.] // European Journal of Endocrinology. - 2016. - Vol. 174, N 5. - P. 1-10.


13. Wang, W. Effectiveness and safety of laparoscopic adrenalectomy of large pheochromocytoma: A prospective, nonrandomized, controlled study / W. Wang [et al.] // Am J. Surg. -2015.-Vol. 210. - P. 230-235.